These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35433768)
21. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192 [TBL] [Abstract][Full Text] [Related]
22. Cardiopulmonary Exercise Test Methodology for Assessing Exertion Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Stevens S; Snell C; Stevens J; Keller B; VanNess JM Front Pediatr; 2018; 6():242. PubMed ID: 30234078 [No Abstract] [Full Text] [Related]
23. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Rowe PC; Underhill RA; Friedman KJ; Gurwitt A; Medow MS; Schwartz MS; Speight N; Stewart JM; Vallings R; Rowe KS Front Pediatr; 2017; 5():121. PubMed ID: 28674681 [TBL] [Abstract][Full Text] [Related]
24. MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME). Petty RD; McCarthy NE; Le Dieu R; Kerr JR PLoS One; 2016; 11(3):e0150904. PubMed ID: 26967895 [TBL] [Abstract][Full Text] [Related]
25. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. van Campen CLMC; Rowe PC; Verheugt FWA; Visser FC Front Med (Lausanne); 2020; 7():602894. PubMed ID: 33585505 [No Abstract] [Full Text] [Related]
26. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study. Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713 [TBL] [Abstract][Full Text] [Related]
27. Shadow Burden of Undiagnosed Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) on Society: Retrospective and Prospective-In Light of COVID-19. Araja D; Berkis U; Lunga A; Murovska M J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300183 [TBL] [Abstract][Full Text] [Related]
28. Contrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Jason LA; Brown A; Clyne E; Bartgis L; Evans M; Brown M Eval Health Prof; 2012 Sep; 35(3):280-304. PubMed ID: 22158691 [TBL] [Abstract][Full Text] [Related]
29. Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. Lidbury BA; Kita B; Lewis DP; Hayward S; Ludlow H; Hedger MP; de Kretser DM J Transl Med; 2017 Mar; 15(1):60. PubMed ID: 28302133 [TBL] [Abstract][Full Text] [Related]
30. Changes in circulating microRNA after recumbent isometric yoga practice by patients with myalgic encephalomyelitis/chronic fatigue syndrome: an explorative pilot study. Takakura S; Oka T; Sudo N Biopsychosoc Med; 2019; 13():29. PubMed ID: 31827600 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of Immune Dysregulation in an Austrian Patient Cohort Suffering from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Lutz L; Rohrhofer J; Zehetmayer S; Stingl M; Untersmayr E Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572574 [TBL] [Abstract][Full Text] [Related]
34. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Maes M; Twisk FN; Ringel K Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503 [TBL] [Abstract][Full Text] [Related]
35. Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms. Twisk FN World J Methodol; 2015 Jun; 5(2):68-87. PubMed ID: 26140274 [TBL] [Abstract][Full Text] [Related]
36. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). de Vega WC; Herrera S; Vernon SD; McGowan PO BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836 [TBL] [Abstract][Full Text] [Related]
37. A definition of recovery in myalgic encephalomyelitis and chronic fatigue syndrome should be based upon objective measures. Twisk FN Qual Life Res; 2014 Nov; 23(9):2417-8. PubMed ID: 24935018 [TBL] [Abstract][Full Text] [Related]
38. Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis. Nehrke PI; Fox PA; Jason LA Neurology (ECronicon); 2017; 7(4):172-178. PubMed ID: 29662969 [TBL] [Abstract][Full Text] [Related]
39. Cellular Immune Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Cliff JM; King EC; Lee JS; Sepúlveda N; Wolf AS; Kingdon C; Bowman E; Dockrell HM; Nacul L; Lacerda E; Riley EM Front Immunol; 2019; 10():796. PubMed ID: 31057538 [TBL] [Abstract][Full Text] [Related]